PRVB - Provention Bio gains after HSR waiting period for Sanofi deal expired
2023-04-26 09:11:32 ET
- Provention Bio ( NASDAQ: PRVB ) rose 3.1% in premarket trading after the HSR antitrust waiting period for the company's sale to Sanofi ( NASDAQ: SNY ) expired. Sanofi rose 1%.
- Sanofi ( SNY ) announced that the HSR waiting period for the Provention Bio ( PRVB ) deal had expired in a statement.
- Sanofi ( SNY ) agreed to acquiring diabetes drugmaker Provention Bio ( PRVB ) for ~$2.9 billion, or $25 a share last month.
For further details see:
Provention Bio gains after HSR waiting period for Sanofi deal expired